Przeciwciała monoklonalne (mAb) podawane w monoterapii lub terapii skojarzonej
stanowią skuteczną opcję terapeutyczną w przypadku nowotworów hematologicznych …

Monoclonal antibodies given as monotherapy or combination therapy have emerged as
effective treatment options for hematologic malignancies. By prolonging survival, mAbs …

Monoclonal antibodies have emerged as effective treat ments for a wide range of
hematological and oncological dis or ders. Even though the majority of these medications …

For many years, chemotherapy, hormonotherapy and immunotherapy were the mainstay of
cancer treatment. Recent advances in our knowledge of cell biology and particularly of …

Przeciwciała monoklonalne (moAb–monoclonal antibodies) są immunoglobulinami, które
zmodyfikowano i zaprojektowano tak, aby nabyły zdolności do wywoływania swoistych i …

This review focuses on the development of monoclonal antibodies that have been or are
being introduced in the treatment of both lymphoid and myeloid haematological …

Introduction: The introduction of monoclonal antibodies (moAbs) into clinical practice
revolutionized the treatment strategies in several solid tumors. These agents differ from …

Hematological tumors are a significant disease that poses a serious threat to human health,
with morbidity and mortality rates ranking among the highest for all types of tumors. Targeted …

Cytotoxic chemotherapy is a group of drugs that are used to treat many conditions. They are,
however, predominately used in the treatment of malignant disorders including …

As hematological malignancies are a growing concern, more targeted chemotherapy
options are being investigated and explored. Monoclonal antibodies play a pivotal role in …